These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26391917)

  • 1. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
    Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
    Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project.
    Florio AA; Campbell PT; Zhang X; Zeleniuch-Jacquotte A; Wactawski-Wende J; Smith-Warner SA; Sinha R; Simon TG; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Renehan AG; Purdue MP; Poynter JN; Palmer JR; Newton CC; Lu Y; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Kirsh VA; Hofmann JN; Graubard BI; Giovannucci E; Gaziano JM; Gapstur SM; Freedman ND; Demuth J; Chong DQ; Chan AT; Buring JE; Bradshaw PT; Beane Freeman LE; McGlynn KA; Petrick JL
    Int J Cancer; 2020 Aug; 147(3):675-685. PubMed ID: 31677159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
    Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
    J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
    Petrick JL; Thistle JE; Zeleniuch-Jacquotte A; Zhang X; Wactawski-Wende J; Van Dyke AL; Stampfer MJ; Sinha R; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Purdue MP; Poynter JN; Palmer JR; Newton CC; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Hofmann JN; Graubard BI; Giovannucci E; Gaziano MJ; Gapstur SM; Freedman ND; Chong DQ; Chan AT; Buring JE; Freeman LBE; Campbell PT; McGlynn KA
    Am J Gastroenterol; 2018 Oct; 113(10):1494-1505. PubMed ID: 30177781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
    Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
    McGlynn KA; Tarone RE; El-Serag HB
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
    Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
    PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.
    Yang B; Petrick JL; Kelly SP; Graubard BI; Freedman ND; McGlynn KA
    Int J Cancer; 2017 Jul; 141(2):271-278. PubMed ID: 28411388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
    Tan RZH; Lockart I; Abdel Shaheed C; Danta M
    Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
    Hwang IC; Chang J; Kim K; Park SM
    Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
    El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
    Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
    Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
    J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
    Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand.
    Pupacdi B; Loffredo CA; Budhu A; Rabibhadana S; Bhudhisawasdi V; Pairojkul C; Sukeepaisarnjaroen W; Pugkhem A; Luvira V; Lertprasertsuke N; Chotirosniramit A; Auewarakul CU; Ungtrakul T; Sricharunrat T; Sangrajrang S; Phornphutkul K; Albert PS; Kim S; Harris CC; Mahidol C; Wang XW; Ruchirawat M;
    Int J Cancer; 2024 Oct; 155(8):1387-1399. PubMed ID: 38761410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank.
    Petrick JL; McMenamin ÚC; Zhang X; Zeleniuch-Jacquotte A; Wactawski-Wende J; Simon TG; Sinha R; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Purdue MP; Poynter JN; Palmer JR; Lu Y; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Kirsh VA; Hofmann JN; Graubard BI; Giovannucci E; Gaziano JM; Gapstur SM; Freedman ND; Florio AA; Chong DQ; Chen Y; Chan AT; Buring JE; Freeman LEB; Bea JW; Cardwell CR; Campbell PT; McGlynn KA
    Br J Cancer; 2020 Jul; 123(2):316-324. PubMed ID: 32376888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.